NIH/National Institute of Allergy and Infectious Diseases
NIH/National Institute of Allergies and Infectious Disease (NIAID) is part of the National Institute of Health, funded through theUSA Department of Health and Human Services, a cabinet level agency. NIAID has been in existence for over 50 years and its primary role is to conduct, support and find effective treatments for infectioius, immunological and allergic diseases. Some of its efforts are conducted in-house, but a significant amount of research funds are awarded to scientists, labs and universities to accomplish NIAID goals. NIAID credits itself with developing new vaccines, new therapies and new diagnostic tests which have aided millions of people.
Address
NIAID Office of Communications and Government Relations
6610 Rockledge Drive, MSC 6612
Bethesda, MD 20892-6612
United States of America
News Office
niaidnews [at] niaid [dot] nih [dot] gov
Phone
301-402-1663
Fax
301-402-0120
Contact
"NIH/National Institute of Allergy and Infectious Diseases" in the news:
New findings suggest strategy to help generate HIV-neutralizing antibodies
Medicine & Health / HIV & AIDS
Nov 19, 2009 |
not rated yet |
0
New discoveries about anti-HIV antibodies may bring researchers a step closer to creating an effective HIV vaccine, according to a new paper co-authored by scientists at the Vaccine Research Center of the National Institute ...
Initial results show pregnant women mount strong immune response to one dose of 2009 H1N1 vaccine
Medicine & Health / Medications
Nov 02, 2009 |
not rated yet |
0
Healthy pregnant women mount a robust immune response following just one dose of 2009 H1N1 influenza vaccine, according to initial results from an ongoing clinical trial sponsored by the National Institute of Allergy and ...
Progress made on group B streptococcus vaccine
Oct 30, 2009 |
not rated yet |
0
Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have completed a Phase II clinical study that indicates a vaccine to prevent Group B Streptococcus ...
NIH launches 2009 H1N1 influenza vaccine trials in HIV-infected pregnant women
Medicine & Health / HIV & AIDS
Oct 10, 2009 |
not rated yet |
0
The first clinical trials to test whether the 2009 H1N1 influenza vaccine can safely elicit a protective immune response in pregnant women launched yesterday, and a trial to conduct the same test in HIV-infected children ...
Frozen assets: Researchers turn to unique resource for clues to norovirus evolution
Oct 01, 2009 |
5 / 5 (1) |
0
A search through decades-old frozen infant stool samples has yielded rich dividends for scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The team ...
Scientists identify genetic cause of previously undefined primary immune deficiency disease
Sep 24, 2009 |
5 / 5 (1) |
0
Researchers at the National Institutes of Health have identified a genetic mutation that accounts for a perplexing condition found in people with an inherited immunodeficiency. The disorder, called combined immunodeficiency, ...
Study finds nontuberculous mycobacteria lung disease on the rise in the United States
Sep 24, 2009 |
not rated yet |
0
Nontuberculous mycobacteria (NTM) are environmental organisms found in both water and soil that can cause severe pulmonary (lung) disease in humans. Pulmonary NTM is on the rise in the United States, according to a large ...
Early results: In children, 2009 H1N1 influenza vaccine works like seasonal flu vaccine
Sep 21, 2009 |
5 / 5 (1) |
0
Early results from a trial testing a 2009 H1N1 influenza vaccine in children look promising, according to the trial sponsor, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes ...
Clinical trial of antiretroviral-based HIV prevention strategies for women now under way
Medicine & Health / HIV & AIDS
Sep 16, 2009 |
not rated yet |
0
A new, large-scale clinical trial is examining whether antiretroviral medications normally used to treat HIV infection can also prevent HIV infection in women when applied as a vaginal gel or taken as oral tablets once daily.
NIAID launches 2009 H1N1 influenza vaccine trial in pregnant women
Medicine & Health / Medications
Sep 09, 2009 |
not rated yet |
0
The first trial testing a candidate 2009 H1N1 influenza vaccine in pregnant women is launching this week, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, announced ...
Scientists study past flu pandemics for clues to future course of 2009 H1N1 virus
Aug 11, 2009 |
not rated yet |
0
A commonly held belief that severe influenza pandemics are preceded by a milder wave of illness arose because some accounts of the devastating flu pandemic of 1918-19 suggested that it may have followed such a pattern. But ...
Searching for predictors of asthma attacks
Aug 10, 2009 |
not rated yet |
0
A new study of persistent asthma in inner-city adolescents and young adults finds that an extensive set of clinical tests cannot successfully predict the future risk of asthma attacks in participants who both receive care ...
Found: A gene that may play a role in type 1 diabetes
Aug 10, 2009 |
5 / 5 (2) |
0
Scientists at Stanford University have identified a gene that may play a role in the development of type 1 diabetes, an autoimmune disease in which the immune system attacks the body's insulin-producing cells. Insulin, a ...
Scientists learn why even treated genital herpes sores boost the risk of HIV infection
Medicine & Health / HIV & AIDS
Aug 02, 2009 |
5 / 5 (1) |
2
New research helps explain why infection with herpes simplex virus-2 (HSV-2), which causes genital herpes, increases the risk for HIV infection even after successful treatment heals the genital skin sores and breaks that ...
Genes key to staph disease severity, drug resistance found hitchhiking together
Jul 31, 2009 |
4 / 5 (2) |
0
Scientists studying Staphylococcus bacteria, including methicillin-resistant S. aureus (MRSA), have discovered a potent staph toxin responsible for disease severity. They also found the gene for the toxin traveling with a geneti ...
